Literature DB >> 29751883

Cholangiocarcinoma.

Alyssa M Krasinskas1.   

Abstract

This article focuses on cholangiocarcinoma, both intrahepatic and extrahepatic. The various classification schemes based on anatomic location, macroscopic growth pattern, microscopic features, and cell of origin are outlined. The clinicopathologic, immunohistochemical and molecular differences between intrahepatic cholangiocarcinoma and extrahepatic cholangiocarcinoma, as well as differences in the 2 subtypes of intrahepatic cholangiocarcinoma, are discussed. Finally, precursor lesions, prognosis, treatment, and promising new potential targeted therapies are reviewed.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bile duct; Cholangiocarcinoma; Extrahepatic; IDH1; IDH2; Intrahepatic

Mesh:

Year:  2018        PMID: 29751883     DOI: 10.1016/j.path.2018.02.005

Source DB:  PubMed          Journal:  Surg Pathol Clin        ISSN: 1875-9157


  32 in total

Review 1.  Development and Characterization of Human Primary Cholangiocarcinoma Cell Lines.

Authors:  Abdulkadir Isidan; Ali Yenigun; Daiki Soma; Eric Aksu; Kevin Lopez; Yujin Park; Arthur Cross-Najafi; Ping Li; Debjyoti Kundu; Michael G House; Sanjukta Chakraborty; Shannon Glaser; Lindsey Kennedy; Heather Francis; Wenjun Zhang; Gianfranco Alpini; Burcin Ekser
Journal:  Am J Pathol       Date:  2022-05-28       Impact factor: 5.770

2.  The clinical and prognostic factors for biliary neuroendocrine neoplasm: a study based on the SEER database.

Authors:  Bo-Hao Zheng; Cheng Zhang; Wen-Ze Wan; Wen-Tao Sun; Xi Cheng; Xiao-Jian Ni; Xiao-Ling Ni; Tao Suo; Han Liu; Sheng Shen; Hou-Bao Liu
Journal:  BMC Surg       Date:  2022-06-29       Impact factor: 2.030

Review 3.  Current challenges to underpinning the genetic basis for cholangiocarcinoma.

Authors:  Antonio Cigliano; Xin Chen; Diego F Calvisi
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2021-04-23       Impact factor: 3.869

4.  Burden of illness for patients with cholangiocarcinoma in the United States: a retrospective claims analysis.

Authors:  Christina X Chamberlain; Elizabeth Faust; Debbie Goldschmidt; Nathan Webster; Audra N Boscoe; Dendy Macaulay; Mary Linton Peters
Journal:  J Gastrointest Oncol       Date:  2021-04

5.  Minimally invasive surgery for hilar cholangiocarcinoma: a multicenter retrospective analysis of 158 patients.

Authors:  Li Jingdong; Xiong Yongfu; Gang Yang; Xu Jian; Huang Xujian; Liu Jianhua; Zhao Wenxing; Qin Renyi; Yin Xinming; Zheng Shuguo; Liang Xiao; Peng Bin; Zhang Qifan; Li Dewei; Tang Zhao-Hui
Journal:  Surg Endosc       Date:  2020-11-30       Impact factor: 4.584

6.  A Novel NIPBL-NACC1 Gene Fusion Is Characteristic of the Cholangioblastic Variant of Intrahepatic Cholangiocarcinoma.

Authors:  Pedram Argani; Doreen N Palsgrove; Robert A Anders; Steven C Smith; Carla Saoud; Regina Kwon; Lysandra Voltaggio; Naziheh Assarzadegan; Kiyoko Oshima; Lisa Rooper; Andres Matoso; Lei Zhang; Brandi L Cantarel; Jeffrey Gagan; Cristina R Antonescu
Journal:  Am J Surg Pathol       Date:  2021-11-01       Impact factor: 6.298

Review 7.  Multifaceted Aspects of Metabolic Plasticity in Human Cholangiocarcinoma: An Overview of Current Perspectives.

Authors:  Mirella Pastore; Giulia Lori; Alessandra Gentilini; Maria Letizia Taddei; Giovanni Di Maira; Claudia Campani; Stefania Recalcati; Pietro Invernizzi; Fabio Marra; Chiara Raggi
Journal:  Cells       Date:  2020-03-03       Impact factor: 6.600

8.  MRPL27 contributes to unfavorable overall survival and disease-free survival from cholangiocarcinoma patients.

Authors:  Liping Zhuang; Zhiqiang Meng; Zongguo Yang
Journal:  Int J Med Sci       Date:  2021-01-01       Impact factor: 3.738

9.  Prognostic and clinicopathological significance of Hapto and Gremlin1 expression in extrahepatic cholangiocarcinoma.

Authors:  Zhengchun Wu; Rushi Liu; Xiongying Miao; Daiqiang Li; Qiong Zou; Yuan Yuan; Zhulin Yang
Journal:  J Cancer       Date:  2020-01-01       Impact factor: 4.207

10.  Suppressive myeloid cells are expanded by biliary tract cancer-derived cytokines in vitro and associate with aggressive disease.

Authors:  Michael B Ware; Mohammad Y Zaidi; Jennifer Yang; Michael K Turgeon; Alyssa Krasinskas; Thomas A Mace; Kaitlin Keenan; Matthew R Farren; Amanda N Ruggieri; Yiman Li; Chao Zhang; Zhengjia Chen; Gregory S Young; Omar Elnaggar; Zheng Che; Shishir K Maithel; Tanios Bekaii-Saab; Bassel El-Rayes; Gregory B Lesinski
Journal:  Br J Cancer       Date:  2020-08-04       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.